Panhandle Royalty Company (PHX) stock soared to a 52-week high, reaching $4.18, as investors rallied behind the company's strong performance over the past year. With a market capitalization of $152.36 ...

Cathie Wood’s ARK line of ETFs made some significant trades yesterday, selling Palantir Technologies (PLTR) and Robinhood ...

Pliant Therapeutics (NASDAQ:PLRX – Get Free Report) had its price target lowered by equities researchers at Needham & Company LLC from $38.00 to $10.00 in a report released on Monday,Benzinga reports.

Pliant Therapeutics (NASDAQ:PLRX – Get Free Report)‘s stock had its “hold” rating restated by research analysts at Canaccord Genuity Group in a note issued to investors on Monday, MarketBeat reports.

Check out the latest The Pnc Financial Services Group Inc. (PNC) stock quote and chart. View real-time stock prices & the company’s financial overview to help with your trading & investment.

Canaccord Genuity has downgraded Pliant (PLRX) to hold following news that the company has paused a clinical trial for its ...

NEW YORK, NY / ACCESS Newswire / February 11, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Pliant ...

Fintel reports that on February 10, 2025, Canaccord Genuity downgraded their outlook for Pliant Therapeutics (NasdaqGS:PLRX) ...

Pliant Therapeutics paused its phase 2b/3 trial of bexotegrast for idiopathic pulmonary fibrosis due to DSMB recommendations.

On Monday, February 10, 2025, the Cathie Wood-led Ark Invest sold nearly $16 million worth of Palantir shares amid a spike in ...